Ian DOUGLAS BSc MSc PhD
- Room 248a
- LSHTM
- Keppel Street
- London
- WC1E 7HT
- T: +44 (0)20 7927 2968
- F: +44 (0)20 7580 6897
I am an epidemiologist, currently funded by an MRC Methodology Fellowship. I initially studied physiology and completed a PhD in Manchester. Since then I have spent several years at the UK Medicines & Healthcare Products Regulatory Agency and in the pharmaceutcial industry investigating adverse effects of drugs - both in clinical trials and post-marketing. I completed the MSc in epidemiology at LSHTM in 2005
Affiliation
Teaching
I am course organiser for the Certificate Course in Pharmacoepidemiology and Pharmacovigilance, and I teach on the Practical Pharmacoepidemiology course as well as some of the units in MSc Epidemiology
Research
I'm interested in pharmacoepidemiology, and in particular, how we can use large primary care databases to investigate the effects of drugs - both harmful and beneficial. I am exploring methodologies to minimise some of the biases inherent in the research of drug effects, and my main current areas of interest are case-only approaches to study design and the use of propensity scores. I'm also investigating how best to use linked sources of data to better define clinical outcomes
Research areas
- Drug discovery and development
- Pharmacovigilance
- Primary care
- Public health
Disciplines
- Epidemiology
- Medicine
- Pharmacoepidemiology
- Pharmacology
Other interests
- Adverse Drug Reactions
- Analysis Of Longitudinal Data
- Pharmaceuticals
-
Selected publications
-
Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials
Smeeth, L.; Douglas, I.; Hall, A.J.; Hubbard, R.; Evans, S.
British Journal of Clinical Pharmacology, 2009; 67(1):99-109
-
The risk of fractures associated with thiazolidinediones: a self-controlled case-series study
Douglas, I.J.; Evans, S.J.; Pocock, S.; Smeeth, L.
PLoS Med, 2009; 6(9):e1000154
-
Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions.
Grosso, A.; Douglas, I.; Hingorani, A.; Macallister, R.; Smeeth, L.;
Br J Clin Pharmacol, 2008; 66(5):689-94
-
Exposure to antipsychotics and risk of stroke: self controlled case series study.
Douglas, I.J.; Smeeth, L.;
BMJ, 2008; 337:a1227
-
A case-control study of drug risk factors for age-related macular degeneration.
Douglas, I.J.; Cook, C.; Chakravarthy, U.; Hubbard, R.; Fletcher, A.E.; Smeeth, L.;
Ophthalmology, 2007; 114(6):1164-9
- → View all Ian DOUGLAS's publications
